Therapeutic hypothermia to preserve residual hearing in veterans receiving cochlear implantation

低温治疗可保护接受人工耳蜗植入的退伍军人的残余听力

基本信息

  • 批准号:
    10616467
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-01 至 2026-02-28
  • 项目状态:
    未结题

项目摘要

The primary goal of this proposal is to test and develop a novel application of therapeutic hypothermia for veterans receiving cochlear implantation (CI) with an aim to preserve residual hearing and sensitive neural structures against surgical trauma and improve hearing outcomes post-implantation. Increasing residual hearing in veterans post-CI will likely improve their speech recognition outcomes, improve speech perception in quiet, and overall, patient benefit and usage of these devices. An increasing number of patients, that include our veterans, have some level of residual hearing at the time of implantation and can benefit from bimodal electro- acoustic devices. Surviving hair cell activity and as a result a functioning organ of Corti and neural substrate has recently been linked to speech perception outcomes. However, trauma during implantation leads to inflammation and oxidative stress that can exacerbate residual hearing loss. Successful translation of therapeutic interventions to limit pathophysiology of the injury have yet to be achieved. The present work aims to develop application(s) of localized, therapeutic hypothermia for protection of hair cells and neural substrate following CI in compromised cochleae as a result of noise and blast exposures in veterans. The specific aims are motivated by a gap in knowledge currently of the pathophysiology of CI in compromised cochleae, its relation to poor outcomes in veterans, and our preliminary data showing that localized, mild hypothermia delivered to the cochlea is effective and safe therapeutic intervention for preserving residual hearing after implantation. The results from this project can be further extended to other inner and middle ear surgeries in veterans, surgeries that also carry a risk of residual hearing loss.
该提案的主要目标是测试和开发一种新的治疗性低温应用, 接受人工耳蜗植入(CI)的退伍军人,旨在保留残余听力和敏感的神经 结构,防止手术创伤和改善植入后的听力结果。增强残余听力 在退伍军人中,CI后可能会改善他们的语音识别结果,改善安静时的语音感知, 以及这些设备的总体患者受益和使用情况。越来越多的患者,包括我们的 退伍军人,在植入时有一定程度的残余听力,可以从双峰电- 声学装置存活的毛细胞活动,并作为一个功能器官的Corti和神经基板, 最近与言语感知结果有关。然而,植入过程中的创伤会导致炎症 和氧化应激会加重残余听力损失。成功翻译治疗干预措施 以限制损伤的病理生理学尚未实现。目前的工作旨在开发应用程序(S) 局部治疗性低温对脑梗死后毛细胞和神经基质的保护作用 退伍军人因噪音和爆炸暴露而导致的耳蜗损伤。具体目标的动机是在以下方面的差距: 目前的知识,CI的病理生理学受损耳蜗,其关系到不良的结果, 我们的初步数据显示,局部,轻度低温传递到耳蜗是有效的 和安全的治疗干预以保留植入后的残余听力。这个项目的成果 可以进一步扩展到退伍军人的其他内耳和中耳手术,手术也有风险, 残余听力损失

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Suhrud M. Rajguru其他文献

Selective Activation of Vestibular Hair Cells by Infrared Light
  • DOI:
    10.1016/j.bpj.2009.12.2760
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Suhrud M. Rajguru;Richard D. Rabbitt;Agnella Izzo Matic;Stephen M. Highstein;Claus-Peter Richter
  • 通讯作者:
    Claus-Peter Richter
Pulsed Infrared-evoked Intracellular Calcium Transients in Neonatal Vestibular and Spiral Ganglion Neurons
脉冲红外诱发新生儿前庭和螺旋神经节神经元的细胞内钙瞬变
Longterm infrared neural stimulation in the chronic implanted cat
对慢性植入猫进行长期红外神经刺激
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. I. Matic;A. Robinson;Hunter Young;Ben Badofsky;Suhrud M. Rajguru;C. Richter
  • 通讯作者:
    C. Richter
Mechanisms Underlying Pulsed Infrared Stimulation of Cardiomyocytes
  • DOI:
    10.1016/j.bpj.2010.12.3577
  • 发表时间:
    2011-02-02
  • 期刊:
  • 影响因子:
  • 作者:
    Gregory M. Dittami;Kenneth W. Spitzer;Suhrud M. Rajguru;Richard A. Lasher;Robert W. Hitchcock;Richard D. Rabbitt
  • 通讯作者:
    Richard D. Rabbitt
Optical Stimulation of Neurons
神经元的光刺激
  • DOI:
    10.1002/9783527632053.ch6
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Suhrud M. Rajguru;A. I. Matic;C. Richter
  • 通讯作者:
    C. Richter

Suhrud M. Rajguru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Suhrud M. Rajguru', 18)}}的其他基金

Therapeutic hypothermia to preserve residual hearing in veterans receiving cochlear implantation
低温治疗可保护接受人工耳蜗植入的退伍军人的残余听力
  • 批准号:
    10314602
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Application of mild therapeutic hypothermia for hearing conservation during cochlear implant surgeries
亚低温治疗在人工耳蜗植入手术中听力保护中的应用
  • 批准号:
    10327695
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Application of mild therapeutic hypothermia for hearing conservation during cochlear implant surgeries
亚低温治疗在人工耳蜗植入手术中听力保护中的应用
  • 批准号:
    10540231
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Pulsed infrared excitability of inner ear: molecular mechanisms and therapeutics
内耳脉冲红外兴奋性:分子机制和治疗
  • 批准号:
    8887896
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Pulsed infrared excitability of inner ear: molecular mechanisms and therapeutics
内耳脉冲红外兴奋性:分子机制和治疗
  • 批准号:
    9014537
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Pulsed infrared excitability of inner ear: molecular mechanisms and therapeutics
内耳脉冲红外兴奋性:分子机制和治疗
  • 批准号:
    9246496
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了